Search research articles
Contact Us
Filters
Showing results (21-30 of 27) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 27 results.
Gene Therapy
|
November 18, 2000
Dendritic cells infected with recombinant fowlpox virus vectors are potent and long-acting stimulators of transgene-specific class I restricted T lymphocyte activity
M Brown, Y Zhang, S Dermine, et al.
International Journal of Cancer
|
December 18, 2001
Human T cell responses to HPV 16 E2 generated with monocyte-derived dendritic cells
E J Davidson, M D Brown, D J Burt, et al.
British Journal of Cancer
|
January 1, 1997
Differences in serological IgA responses to recombinant baculovirus-derived human papillomavirus E2 protein in the natural history of cervical neoplasia
L Rocha-Zavaleta, D Jordan, S Pepper, et al.
Lancet (London, England)
|
June 1, 1996
A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer
L K Borysiewicz, A Fiander, M Nimako, et al.
International Journal of Cancer
|
August 30, 2000
Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes in women with cervical neoplasia
H J Bontkes, T D de Gruijl, A J van den Muysenberg, et al.
Journal of Medical Genetics
|
January 8, 2008
CDKN2A mutations and melanoma risk in the Icelandic population
A M Goldstein, S N Stacey, J H Olafsson, et al.
Translational Psychiatry
|
October 7, 2015
Genome-wide meta-analysis reveals common splice site acceptor variant in CHRNA4 associated with nicotine dependence
D B Hancock, G W Reginsson, N C Gaddis, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 27) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 27 results.
Gene Therapy
|
November 18, 2000
Dendritic cells infected with recombinant fowlpox virus vectors are potent and long-acting stimulators of transgene-specific class I restricted T lymphocyte activity
M Brown, Y Zhang, S Dermine, et al.
International Journal of Cancer
|
December 18, 2001
Human T cell responses to HPV 16 E2 generated with monocyte-derived dendritic cells
E J Davidson, M D Brown, D J Burt, et al.
British Journal of Cancer
|
January 1, 1997
Differences in serological IgA responses to recombinant baculovirus-derived human papillomavirus E2 protein in the natural history of cervical neoplasia
L Rocha-Zavaleta, D Jordan, S Pepper, et al.
Lancet (London, England)
|
June 1, 1996
A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer
L K Borysiewicz, A Fiander, M Nimako, et al.
International Journal of Cancer
|
August 30, 2000
Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes in women with cervical neoplasia
H J Bontkes, T D de Gruijl, A J van den Muysenberg, et al.
Journal of Medical Genetics
|
January 8, 2008
CDKN2A mutations and melanoma risk in the Icelandic population
A M Goldstein, S N Stacey, J H Olafsson, et al.
Translational Psychiatry
|
October 7, 2015
Genome-wide meta-analysis reveals common splice site acceptor variant in CHRNA4 associated with nicotine dependence
D B Hancock, G W Reginsson, N C Gaddis, et al.
Page
of 3